Absci Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABSI Nasdaq 2834 www.absci.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Absci Corporation

Independent Director of Absci Picks Up 454% More Stock - Dec 11th, 2025 11:47 am
Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization - Dec 11th, 2025 6:00 am
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Dec 10th, 2025 6:00 am
Absci (ABSI) Is Up 12.9% After Starting Phase 1/2a Trials For AI-Designed ABS-201 - Dec 5th, 2025 7:07 pm
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study - Dec 5th, 2025 8:37 am
Absci (ABSI): Assessing Valuation as AI‑Designed Hair Loss Drug Enters First Phase 1/2a Trial - Dec 4th, 2025 8:09 am
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - Dec 4th, 2025 6:00 am
Absci (ABSI) Valuation in Focus as Clinical Expansion and Partnership Efforts Gather Pace - Nov 16th, 2025 10:09 am
Is Absci’s (ABSI) Lower Per-Share Loss a Sign of Rising Efficiency or Just a Temporary Shift? - Nov 13th, 2025 9:34 pm
Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... - Nov 12th, 2025 10:02 pm
Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 3:25 pm
Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results - Nov 12th, 2025 2:05 pm
uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates - Nov 10th, 2025 6:15 am
Invivyd, Inc. (IVVD) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 7:15 am
Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Oct 29th, 2025 2:05 pm
Absci to Participate in Upcoming Investor Conferences - Oct 27th, 2025 6:00 am
Can Absci’s (ABSI) Accelerated Hair Loss Trial Timeline Reveal An Edge in Biotech Innovation? - Oct 18th, 2025 12:11 am
Absci (ABSI) Valuation in Focus as Early ABS-201 Hair Loss Trial Draws Investor Attention - Oct 15th, 2025 11:06 pm
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial - Oct 15th, 2025 6:00 am
Insider Spends US$255k Buying More Shares In Absci - Sep 27th, 2025 6:16 am